Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Mad Paws becoming the ‘go-to’ for pet products and services with their latest acquisition

  • In News
  • February 23, 2022
  • Samantha Freidin
Mad Paws becoming the ‘go-to’ for pet products and services with their latest acquisition

I don’t do much without my little brindle side kick. She comes to the office, on dates, and Bunnings runs. I always order her a side of bacon on brunch outings and she frequently enjoys some cheeky nuggets when we find ourselves at a Maccas drive through. She exemplifies ‘man’s best friend’. 

Unsurprisingly many Australians have added some fur to their family with 6.8 million households nationwide owning a pet, 15% higher than pre-pandemic. 

The lift in pet ownership has seen a marked increase in demand for pet related goods and services where a few companies have benefitted. We spend a whopping $20.5 billion on dogs, and $10.5 billion on cats per year. That cute plush wine bottle was too cute to pass up though, I mean honestly (see picture above). 

Mad Paws (ASX: MPA) is one of those, having originally begun as a pet care marketplace it has now expanded into a robust pet services and products business. The Mad Paws marketplace allows pet owners to find services like pet sitting, dog walking and grooming.

Mad Paws also offers a subscription pet meal service called Dinner Bowl and a toys and treats subscription box through their recently acquired brand, Waggly Club. 

MPA is now extending their reach in line with their strategy to move into health verticals to include your pet’s medical needs, adding Pet Chemist Online to their portfolio. The business is a prominent supplier of pet medication and healthcare products and managed to rake in $5.4 million in revenue, breaking even on their EBITDA in FY21. Pet Chemist boasts over 44,000 active customers with 64% of their monthly sales being from repeat customers. 

“The combination of Mad Paws and Pet Chemist creates a dominant market leader in online pet medication and premium pet healthcare products with significant growth potential,” said Justus Hammer, Co-Founder and CEO of Mad Paws. “We are delighted to welcome the Founders of Pet Chemist, Howard and Mel, and the rest of the team to Mad Paws and look forward to accelerating the combined Group’s growth and performance.”

Mad Paws will pay $25 million for 100% ownership of Pet Chemist Online, $14.5 million of that will be in MPA shares issued at a 16% premium. Initial consideration will also include $5.5 million in cash. The remaining $5 million will be payable based on revenue performance hurdles over the next two years and will be paid out in a combination of MPA shares and cash. 

The acquisition will be finalised in April 2022, pending shareholder approval.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • justus hammer
  • mad paws
  • mpa asx mpa
  • pet chemist online
  • waggly club
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.